Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Two biomarkers may be associated with cardiovascular events and death in type 2 diabetes patients, researchers reported at EASD.…
Read More »EASD: No Microvascular Benefit with Intense BP, Glucose Control
Aggressively lowering blood pressure and blood glucose together won’t provide any microvascular benefits to type 2 diabetes patients, researchers said….
Read More »Post Prandial Elevations Linked to Alzheimer’s Risk
Dementia risk may rise when glucose gets out of control, particularly after meals, according to a longitudinal study.…
Read More »Miglitol Increases GLP-1 Levels for Patients Treated with Sitagliptin
Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin….
Read More »EASD: Diabetes Estimate Now 366 Million
According to the latest figures from the International Diabetes Federation (IDF), released in advance of a UN summit on non-communicable diseases, 366 million people worldwide now have diabetes.…
Read More »EASD: Intensive Glucose Control Cuts Renal Risks
Intensive glucose-lowering may protect against end-stage renal disease (ESRD) in diabetic patients, according to an analysis of data from the ADVANCE trial….
Read More »EASD: First Injection-free Once-A-Year GLP-1
ITCA 650, injection-free continuous delivery of GLP-1 therapy, demonstrated significant and sustained reductions in HbA1c and body weight over 48 weeks of treatment with a marked reduction in the GI AEs typically associated with this class.…
Read More »EASD: Poor Glucose Control in Diabetics Predicts Heart Failure
A new nationwide analysis of glucose management in type 2 diabetes suggests that poor glucose control is a strong predictor of heart failure.…
Read More »EASD: Twice-Daily Aspirin Betters Platelet Inhibition for People with Diabetes
Twice-daily aspirin administration, but not a once-daily doubling of the dose, appears to provide good inhibition of platelet cyclooxygenase (COX)-1 in diabetic patients who have rapid recovery of COX-1 activity, and might enhance cardiovascular protection.…
Read More »EASD: Having Diabetes and Feeling Bad Add Up to Shorter Life
Men with type 2 diabetes and an acute myocardial infarction who score lower on quality-of-life measures have a greater mortality risk than other men with these conditions whose scores indicate they feel better about their health, researchers reported.…
Read More »